Home / Recalls / Rubicon Research Private Limited / D-0659-2024

D-0659-2024 Class III Ongoing

Recalled by Rubicon Research Private Limited — Ambarnath

Recall Details

Product Type
Drugs
Report Date
September 25, 2024
Initiation Date
August 24, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,984 bottles

Product Description

AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01

Reason for Recall

Discoloration

Distribution Pattern

Nationwide in the US

Code Information

Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01

Other recalls by Rubicon Research Private Limited

  • D-0517-2024 Class II — Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed b (May 6, 2024)
  • D-0487-2024 Class II — traMADol Hydrochloride Tablets, USP 50 mg, 1000-count bottle, Rx Only, Distribut (April 26, 2024)
  • D-0362-2022 Class II — Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distribute (December 31, 2021)